ResMed RMD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $398.73M+1.6% | $392.59M+12.6% | $348.54M-8.2% | $379.71M+4.0% | $365.04M+5.9% | ||
| $58.98M+18.2% | $49.89M+4.6% | $47.7M-25.0% | $63.63M+45.7% | $43.68M-6.0% | ||
| $26.79M-7.4% | $28.94M+36.8% | $21.16M-14.5% | $24.75M+2.6% | $24.12M+6.6% | ||
| $16.86M-76.8% | $72.68M+343% | -$29.97M-675% | $5.22M-87.0% | $40.03M-41.0% | ||
| -$12.48M+52.2% | -$26.13M-278% | $14.66M-54.4% | $32.13M— | —— | ||
| $103.88M+876% | $10.65M+39.4% | $7.64M-84.4% | $49.09M-22.2% | $63.09M+1,395% | ||
| $48.34M-54.6% | $106.39M+4,702% | -$2.31M+95.1% | -$47.02M+40.8% | -$79.36M-282% | ||
| -$10.13M— | —— | -$6.19M-144% | -$2.53M+55.1% | -$5.65M-292% | ||
| $10.05M-19.2% | $12.45M+24.8% | $9.97M-6.5% | $10.66M+29.4% | $8.24M-13.0% | ||
| —— | —— | —— | $911K0.0% | $911K0.0% | ||
| $554.13M+63.1% | $339.75M-25.7% | $457.32M-15.1% | $538.77M-6.9% | $578.66M+87.5% | ||
| $33.65M+17.9% | $28.54M-33.6% | $42.97M+40.5% | $30.59M+47.1% | $20.8M+0.7% | ||
| $24.88M— | —— | $522K-99.6% | $138.58M— | $0-100% | ||
| $20.13M+376% | $4.23M+94.7% | $2.17M+7.9% | $2.01M-1.9% | $2.05M+105% | ||
| $2.5M+901% | $250K— | $0-100% | $250K— | $0-100% | ||
| —— | —— | $2.81M-73.9% | $10.78M— | $0+100% | ||
| -$58.03M-13.9% | -$50.94M+3.1% | -$52.58M+60.7% | -$133.71M-321% | -$31.79M+13.4% | ||
| $87.24M-0.4% | $87.58M-0.2% | $87.75M+13.1% | $77.59M-0.1% | $77.7M0.0% | ||
| $175.01M0.0% | $175.01M+16.7% | $150.01M+50.0% | $100.01M+33.3% | $75.03M+0.1% | ||
| —— | $5M— | $0-100% | $5M— | $0-100% | ||
| $7.43M-74.9% | $29.56M+260% | $8.21M-72.8% | $30.16M+234% | $9.02M-66.4% | ||
| $418K-97.9% | $20.31M+2,724% | $719K+21.9% | $590K+62.1% | $364K-97.8% | ||
| -$255.24M+1.2% | -$258.35M-12.2% | -$230.27M-40.5% | -$163.89M-13.8% | -$144.07M+2.3% | ||
| $2.58M-6.7% | $2.77M+3,997% | -$71K-100% | $35.57M+347% | $7.96M+128% | ||
| $243.44M+633% | $33.22M-81.0% | $174.4M-37.0% | $276.74M-32.6% | $410.77M+330% | ||
| $6.53M-1.2% | $6.61M-3.5% | $6.85M-0.9% | $6.91M-51.4% | $14.22M— | ||
| $71.67M-51.4% | $147.55M+138% | $61.87M+282% | $16.18M— | —— | ||
| -$10.13M— | —— | -$6.19M-144% | -$2.53M+55.1% | -$5.65M-292% | ||
| $1.72M+13.4% | $1.52M+1.7% | $1.49M+17.3% | $1.27M+279% | $335K-68.9% | ||
| —— | —— | —— | $911K0.0% | $911K0.0% | ||
| $48.34M-54.6% | $106.39M+4,702% | -$2.31M+95.1% | -$47.02M+40.8% | -$79.36M-282% | ||
| —— | —— | —— | $0— | $0— | ||
| $10.05M-19.2% | $12.45M+24.8% | $9.97M-6.5% | $10.66M+29.4% | $8.24M-13.0% | ||
| $5.94M— | —— | —— | —— | $2.99M— | ||
| -$24.07M-294% | $12.41M+202% | $4.1M+110% | -$40.41M— | —— | ||
| $24.88M— | —— | $522K-99.6% | $138.58M— | $0-100% | ||
| —— | —— | $2.81M-73.9% | $10.78M— | $0+100% | ||
| $2.5M+901% | $250K— | $0-100% | $250K— | $0-100% | ||
| —— | —— | —— | $2.71M0.0% | $2.71M0.0% | ||
| $0— | $0— | $0— | —— | —— | ||
| —— | —— | —— | $0— | $0— | ||
| -$3.17M— | $0— | $0— | —— | —— | ||
| —— | —— | —— | $670K— | $0— | ||
| $18.94M— | —— | $1.32M-98.7% | $101.32M— | $0— | ||
| $71.67M-51.4% | $147.55M+138% | $61.87M+282% | $16.18M— | —— | ||
| $15.61M— | —— | -$798K-102% | $43.53M— | $0— | ||
| $520.48M+67.2% | $311.21M-24.9% | $414.36M-18.5% | $508.18M-8.9% | $557.87M+93.7% | ||
| $520.48M+67.2% | $311.21M-24.9% | $414.36M-18.5% | $508.18M-8.9% | $557.87M+93.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
